Delivery Order SPE2DB22D3016-SPE2DB23FAZN9

Award Date 4/27/23
Potential Completion Date 4/28/23
Potential Value $6.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product. The ceiling value of the contract is $1,759.76, with a firm fixed-price pricing type. The contract is a delivery order against an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,226.75 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of February 6, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB23FT9K2) valued at $1,072.54 for the supply of 1,200,000 units of Bicillin L-A, a penicillin medication, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of April 6, 2023 and is a firm fixed-price arrangement. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,246.04 for the supply of 1,200,000 units of Bicillin L-A 2ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on August 31, 2022, with a completion date of September 1, 2022. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, with an award value of $6,320.21, is for the delivery of 2,400,000 units of Bicillin L-A, a pharmaceutical product, to support military healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
This federal contract award, valued at $78,031.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, with a completion date of November 1, 2022. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense and Department of Veterans...
This federal contract award is for the delivery of Bicillin L-A, a prescription antibiotic medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,186.71, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 16, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,347.18, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,072.54, is for the delivery of 1,200,000 units of Bicillin L-A 2ml, a prescription antibiotic medication, with a completion date of July 17, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,658.87 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a 2mL injectable medication. The contract has an ultimate completion date of August 25, 2022 and was awarded on August 24, 2022. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB23FAZN9
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a ceiling value of $6,901.98. The contract is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA and Department of Defense (DoD) healthcare programs. This contract award is not designated as a set-aside and was awarded through full and open competition. The contract has an ultimate completion date of April 28, 2023.

Generated 5/9/25, 9:59 AM